What is NDC 53877-108?

53877-108 is the product NDC for TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood, Anhydrous citric acid 2.99 g/1000mL + 4 more ingredients solution, listed with the FDA by Terumo Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood (Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine).

What is the active ingredient?

Anhydrous citric acid, Trisodium citrate dihydrate, Sodium phosphate, Monobasic, Monohydrate, Dextrose monohydrate, Adenine.

Terumo Corporation, NDC labeler code 53877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 53877-108

NDC codes

FDA NDC Directory

Product NDC (as listed)53877-108Labeler and product segments. Claims need a package NDC.

Product NDC at billing width53877-0108Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
53877-108-06	5387701080653877010806	6 BLISTER PACK in 1 CASE (53877-108-06) / 4 BAG in 1 BLISTER PACK (53877-108-01) / 63 mL in 1 BAG (53877-108-02)Marketed from Dec 14, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood
Generic name (nonproprietary): anhydrous citric acid, trisodium citrate dihydrate, sodium phosphate, monobasic, monohydrate, dextrose monohydrate, and adenine
Active ingredients: Anhydrous citric acid — 2.99 g/1000mLTrisodium citrate dihydrate — 26.3 g/1000mLSodium phosphate, Monobasic, Monohydrate — 2.22 g/1000mLDextrose monohydrate — 31.9 g/1000mLAdenine — .275 g/1000mL
Dosage form: Solution
Route: Intravenous
Labeler: Terumo CorporationNDC labeler code 53877
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication BN 820528
Marketing start: Dec 14, 2009
Listing expires: Dec 31, 2026
Other FDA classes: Acidifying Activity (Mechanism)Acidifying Activity (Mechanism)Calcium Chelating Activity (Mechanism)Calcium Chelating Activity (Mechanism)Decreased Coagulation Factor Activity (Physiologic effect)Decreased Coagulation Factor Activity (Physiologic effect)
Identifiers: Product ID 53877-108_1c357037-16d2-4bd1-9100-611326e8a468SPL ID 1c357037-16d2-4bd1-9100-611326e8a468SPL set ID 02015040-9b71-4dbe-8f8d-e0d0951e8f93UNII XF417D3PSL, B22547B95K, 593YOG76RN, LX22YL083G, JAC85A2161
Pharmacologic class: Anti-coagulant; Calculi Dissolution Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N453877010806 followed by a unit qualifier and the quantity

Package 53877-0108-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 19, 2024.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE 1.1. Read these instructions carefully before use. 1.2. Rx ONLY. 1.3. Intended for the collection, processing and preservation of Whole Blood and blood components. Not intended for direct intravenous infusion. 1.4. For the collection of 450 mL ±10% or 500 mL ±10% Whole Blood. 1.5. Integral Diversion Blood Sampling Arm is intended to divert and obtain donor samples for laboratory testing prior to collection of the Whole Blood unit. 1.6. For further processing, use standard component processing techniques.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 53877-108

What is NDC 53877-108?: 53877-108 is the product NDC for TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood, Anhydrous citric acid 2.99 g/1000mL + 4 more ingredients solution, listed with the FDA by Terumo Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood (Anhydrous Citric Acid, Trisodium Citrate Dihydrate, Sodium Phosphate, Monobasic, Monohydrate, Dextrose Monohydrate, and Adenine).
What is the active ingredient?: Anhydrous citric acid, Trisodium citrate dihydrate, Sodium phosphate, Monobasic, Monohydrate, Dextrose monohydrate, Adenine.
Who is the labeler?: Terumo Corporation, NDC labeler code 53877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under BN 820528

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BN 820528
Product	Strength	Form · route	Labeler	Product NDC
teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1anhydrous citric acid, trisodium citrate dihydrate, sodium phosphate, monobasic, monohydrate, dextrose monohydrate, and adenine	Anhydrous citric acid 2.99 g/1000mL + 4 more ingredients	SolutionIntravenous	Terumo Corporation	53877-110
TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1anhydrous citric acid, trisodium citrate dihydrate, sodium phosphate, monobasic, monohydrate, dextrose monohydrate, and adenine	Anhydrous citric acid 2.99 g/1000mL + 4 more ingredients	SolutionIntravenous	Terumo Corporation	53877-109

TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood NDC 53877-108